Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

seekingalpha.com - Albert Anthony - TPG Mortgage Investment Trust: A High-Yield REIT Reflecting Neutral Market Signals
TPG Mortgage Investment Trust: A High-Yield REIT Reflecting Neutral Market Signals
Seeking Alpha

Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…

yahoo.com - Ricardo Pillai - Is TG Therapeutics, Inc. (TGTX) A Good Stock To Buy Now?
Is TG Therapeutics, Inc. (TGTX) A Good Stock To Buy Now?
Yahoo!

Is TGTX a good stock to buy? We came across a bullish thesis on TG Therapeutics, Inc. on TradersPro's Substack. In this article, we will summarize the bulls' thesis on TGTX. TG Therapeutics, Inc.'s share was trading at $50.54 as of June 16. TGTX's…

yahoo.com - Ricardo Pillai - Is Caris Life Sciences, Inc. (CAI) A Good Stock To Buy Now?
Is Caris Life Sciences, Inc. (CAI) A Good Stock To Buy Now?
Yahoo!

Is CAI a good stock to buy? We came across a bullish thesis on Caris Life Sciences, Inc. on InfoArb Sheets's Substack. In this article, we will summarize the bulls' thesis on CAI. Caris Life Sciences, Inc.'s share was trading at $18.47 as of June…

seekingalpha.com - Albert Anthony - Americold Realty Trust: A Chilly Upside For Cold-Storage REIT That Grew Globally
Americold Realty Trust: A Chilly Upside For Cold-Storage REIT That Grew Globally
Seeking Alpha

Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…

medpagetoday.com - New Position Statement on TB Testing and IL Inhibitors in Patients With Psoriasis
New Position Statement on TB Testing and IL Inhibitors in Patients With Psoriasis
Medpage Today

A new Joint Position Statement from the National Psoriasis Foundation concludes that patients being treated with IL-17 or IL-23 inhibitors need not be tested for latent tuberculosis (TB) infection in most cases. The statement was released in March…

news-medical.net - Accelerating drug discovery through AI, automation, and next-generation DMTA
Accelerating drug discovery through AI, automation, and next-generation DMTA
News-Medical

insights from industryJon Wingfield & Wenshu Xu Senior Business Development Leader & Head of Drug Discovery Tool at TTP In this interview, industry experts Jon Wingfield and Wenshu Xu from TTP discuss the technologies and strategies transforming…

rt.com - RT - Fauci lied under oath over Covid-19 probe - DNI Gabbard
Fauci lied under oath over Covid-19 probe - DNI Gabbard
RT International

Anthony Fauci used his position as the leading Covid-19 adviser under two US administrations to steer scrutiny away from the so-called lab leak theory and protect himself from possible accountability, outgoing US Director of National Intelligence…

redstate.com - Susie Moore - Gabbard Leaves With a Bang, Blowing the Lid Off Fauci's COVID Cover-Up
Gabbard Leaves With a Bang, Blowing the Lid Off Fauci's COVID Cover-Up
redstate.com

Thursday was Tulsi Gabbard's last day as the Director of National Intelligence, as she departs the Trump administration to address her husband's battle with bone cancer. While the tussle over her replacement proceeds, Gabbard made a point on her…

fool.com - James Halley - Teva Just Delivered More Good News on Its Biggest Growth Driver. Is the Stock Still a Bargain?
Teva Just Delivered More Good News on Its Biggest Growth Driver. Is the Stock Still a Bargain?
The Motley Fool

Teva Pharmaceuticals (TEVA 3.32%) is morphing from a generic drug maker into one that develops more innovative -- and profitable -- drugs. The stock is up more than 10% this year, and more than 95% over the past year. On June 8, the company…

cityam.com - Rosie Harris-Davison - Regulator wins decade-long pricing tussle with Pfizer
Regulator wins decade-long pricing tussle with Pfizer
City AM

The UK competition watchdog has won permission to appeal in a case against US pharmaceutical giant Pfizer after a long-running legal battle over allegations of excessive pricing, overturning a previous decision by the Tribunal. The court said the…

cyclingnews.com - Alasdair Fotheringham - Tour of Slovenia: Laurence Pithie strikes again with searing sprint on stage 3
Tour of Slovenia: Laurence Pithie strikes again with searing sprint on stage 3
Cyclingnews

Race leader Laurence Pithie (Red Bull-Bora-Hansgrohe) took a second bunch sprint victory in three days at the Tour of Slovenia, narrowly outpowering Stefano Oldani (Caja Rural-Seguros RGA) in the final metres. After hard work by the German…

bleepingcomputer.com - Lawrence Abrams - Klue OAuth breach victim list grows as Icarus hackers claim attack
Klue OAuth breach victim list grows as Icarus hackers claim attack
BleepingComputer

Market intelligence platform Klue has publicly confirmed a recent security incident that allowed threat actors to steal OAuth tokens used to connect to customers' Salesforce environments, as the new 'Icarus' extortion group publicly claims the…

politico.eu - Helen Collis - Germany warns US not to jeopardize trade truce with drug pricing probe
Germany warns US not to jeopardize trade truce with drug pricing probe
POLITICO

“I assume that the United States of America will honor the agreement,” Chancellor Friedrich Merz told journalists Friday after meeting with EU leaders in Brussels. That includes “caps on pharmaceutical tariffs,” a German…

medpagetoday.com - Complete Response, Potential Cure With Systemic Chemotherapy in Metastatic Gastric Cancer
Complete Response, Potential Cure With Systemic Chemotherapy in Metastatic Gastric Cancer
Medpage Today

This Reading Room is a collaboration between MedPage Today and: Incorporation of molecular targeted agents and immunotherapy into standard first-line chemotherapy has significantly increased the rates of complete response (CR) and overall survival…

thehindubusinessline.com - India could be on the radar for AstraZeneca's oral GLP-1 drug: MD
India could be on the radar for AstraZeneca's oral GLP-1 drug: MD
BusinessLine

As biopharmaceutical drugmaker AstraZeneca waits in the wings with its oral GLP-1 weight loss and diabetes drug — India could be on its radar, depending on the data from its global Phase III trials, a top AZ executive said. “We are…

Receive a Daily briefing on Pharma Industry News

Get Started